Expression of interleukin-4 receptor and ccl5 chemokine is not related to insect bite hypersensitivity in horses

Peeters, L. M.; Schroyen, Martine; Coussé, A.; De Keyser, K.; Buys, N.

doi:10.1016/j.jevs.2012.10.001

Request a copy

Article (Scientific journals)

Expression of interleukin-4 receptor and ccl5 chemokine is not related to insect bite hypersensitivity in horses

Peeters, L. M.; Schroyen, Martine; Coussé, A. et al.

2013 • In Journal of Equine Veterinary Science, 33 (8), p. 667-669

Peer Reviewed verified by ORBi

Permalink
https://hdl.handle.net/2268/209864

DOI
10.1016/j.jevs.2012.10.001

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

Peeters.pdf

Publisher postprint (215.31 kB)

Request a copy

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Keywords :

Expression study; Horse; Insect bite hypersensitivity; QRT-PCR; Equidae; Hexapoda

Abstract :

[en] Insect bite hypersensitivity (IBH) in horses represents a type I or sometimes a type IV hypersensitivity to salivary antigens from numerous Culicoides spp and some other insects. Until now, there has been no curative treatment available, but there are clear indications that the susceptibility to IBH is partly heritable. Identification of equine genes that are associated with susceptibility to IBH could lead to the development of a marker-assisted selection method. The aim of this study was to investigate the expression of functional candidate genes in relation to IBH. Based on literature, the interleukin-4 receptor (IL4R) and chemokine CCL5 (CCL5) genes were selected for examination by quantitative reverse transcription-PCR (qRT-PCR). Expression levels were determined in 16 horses: 8 IBH-positive horses, all showing clinical IBH symptoms at sampling; and 8 IBH-negative horses, stabled at the same location (case-control set up). Peripheral blood mononuclear cells (PBMC) were isolated from whole- blood samples, and expression levels of IL4R and CCL5 were measured. No differential expression was found for IL4R and CCL5 in PBMC between IBH-positive and IBH-negative horses (P=58 and P=63). Expression of CCL5 and IL4R in PBMC is not related to insect bite hypersensitivity in warmblood horses. Research toward a marker-assisted selection procedures could reduce IBH prevalence in horse populations by means of selection. © 2013 Elsevier Inc.

Disciplines :

Animal production & animal husbandry

Author, co-author :

Peeters, L. M.; Research group Livestock genetics, Department biosystems, Kasteelpark arenberg 30, Heverlee 3001, Belgium

Schroyen, Martine ; Université de Liège > Agronomie, Bio-ingénierie et Chimie (AgroBioChem) > Zootechnie

Coussé, A.; Research group Livestock genetics, Department biosystems, Kasteelpark arenberg 30, Heverlee 3001, Belgium

De Keyser, K.; Research group Livestock genetics, Department biosystems, Kasteelpark arenberg 30, Heverlee 3001, Belgium

Buys, N.; Research group Livestock genetics, Department biosystems, Kasteelpark arenberg 30, Heverlee 3001, Belgium

Title :

Expression of interleukin-4 receptor and ccl5 chemokine is not related to insect bite hypersensitivity in horses

Publication date :

2013

Journal title :

Journal of Equine Veterinary Science

ISSN :

0737-0806

eISSN :

1542-7412

Publisher :

Elsevier, New York, United States - New York

Volume :

Issue :

Pages :

667-669

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 24 April 2017

Statistics

Number of views

61 (2 by ULiège)

Number of downloads

1 (1 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

Bibliography

Fadok V.A., Foil C.F. Equine insect hypersensitivity workshop report 2. Adv. Vet. Dermatol 1990, 1:390-394.
Schurink A., Ducro B., Heuven H.C.M., et al. Genetic parameters of insect bite hypersensitivity in Dutch Friesian broodmares. J Anim Sci 2011, 89:1286-1293.
Roman M., Calhoun W.J., Hinton K.L., et al. Respiratory syncytial virus infection in infants is associated with predominant Th-2-like response. Am J Respir Crit Care Med 1997, 156:190-195.
Nelms K., Huang H., Ryan J., et al. Interleukin-4 receptor signalling mechanisms and their biological significance. Adv Exp Med Biol 1998, 452:37-43.
Woitsch B., Carr D., Stachel D., et al. A comprehensive analysis of interleukin-4 receptor polymorphisms and their association with atopy and IgE regulation in childhood. Int Arch Allergy Immunol 2004, 135:319-324.
Loza M.J., Chang B. Association between Q551R IL4R genetic variants and atopic asthma risk demonstrated by meta-analysis. Clin Exp Allergy 2007, 120:578-585.
Li X., Zhang Y., Zhang J., et al. Asthma susceptible genes in Chinese population: a meta-analysis. Respir Res 2010, 11:129.
Renz H., Jujo K., Bradley K.L., et al. Enhanced IL-4 production and IL-4 receptor expression in atopic dermatitis and their modulation by interferon-gamma. J Invest Dermatol 1992, 99:403-408.
Taha R.A., Leung D.Y.M., Ghaffar O., et al. Invivo expression of cytokine receptor mRNA in atopic dermatitis. J Allergy Clin Immunol 1998, 102:245-250.
Kotsimbos T.C., Ghaffar O., Minshall E.M., et al. Expression of the IL-4 receptor a-subunit is increased in bronchial biopsy specimens from atopic and nonatopic asthmatic subjects. J Allergy Clin Immunol 1998, 102:859-866.
Kiyohara C., Tanaka K., Miyake Y. Genetic susceptibility to atopic dermatitis. Allergol Int 2008, 57:39-56.
Conti P., Barbacane R.C., Reale M. Chemokines in inflammatory states. Allergy Asthma Proc 1999, 20:205-208.
Nickel R.G., Casolaro V., Wahn U., et al. Atopic dermatitis is associated with a functional mutation in the promoter of the C-C chemokine RANTES. J Immunol 2000, 164:1612-1616.
Zhang Y.G., Zhang J., Li X.B., et al. RANTES gene polymorphisms and asthma risk: a meta-analysis. Arch Med Res 2010, 41:50-58.
Bai B., Tanaka K., Tazawa T., et al. Association between RANTES promoter polymorphism -401A and enhanced RANTES production in atopic dermatitis patients. J Dermatol Sci 2005, 39:189-191.
Glück J., Rogala B. Chemokine RANTES in atopic dermatitis. Arch Immunol Ther Exp 1999, 47:367-372.
Niwa Y. Elevated RANTES levels in plasma or skin and decreased plasma IL-10 levels in subsets of patients with severe atopic dermatitis. Arch Dermatol 2001, 136:125-126.
Chihara J., Yasuba H., Tsuda A., et al. Elevation of the plasma level ofRANTES during asthma attacks. J Allergy Clin Immunol 1997, 100:52-55.
Teran L.M., Noso N., Carroll M. Eosinophil recruitment following allergen challenge is associated with the release of the chemokine RANTES into asthmatic airways. J Immunol 1996, 157:1806-1812.
Berkman N., Krishnan V.L., Gilbey T., et al. Expression of RANTES mRNA and protein airways with mild asthma. J Respir Crit Care Med 1996, 154:1804-1811.
Bogaert L., Van Poucke M., De Baere C., et al. Selection of a set of reliable reference genes for quantitative real-time PCR in normal equine skin and in equine sarcoids. BMC Biotechnol 2006, 6:1472-1478.
Zhang Y.W., Davis E.G., Bai J. Determination of internal control for gene expression studies in equine tissues and cell culture using quantitative RT-PCR. Vet Immunol Immunopathol 2009, 130:114-119.
Vandesompele J., De Preter K., Pattyn F., et al. Accurate normalization of real-time quantitative RT-PCR data by geometrix averaging of multiple internal control genes. Genome Biol 2002, 18:0034.1-0034.11.
Hatano Y., Katagiri K., Takayasu S. Increased levels invivo of mRNAs for IL-8 and macrophage inflammatory protein 1alfa (MIP-1alfa), but not of RANTES mRNA in peripheral blood mononuclear cells ofpatients with atopic dermatitis (AD). Clin Exp Allergy 1999, 177:237-243.
Kodama N., Yamaguchi E., Hizawa N., et al. Expression of RANTES by bronchoalveolar lavage cells in nonsmoking patients with interstitial lung diseases. Am J Respir Cell Mol Biol 1998, 18:526-531.
Oyamada H., Hirasawa H., Yamguchi K., et al. Mononuclear cells in response to the specific allergen in asthma patients. Allergol Int 2006, 55:253-259.